KYORIN has been granted a patent for a compound with antiviral properties against picornavirus genus, specifically rhinovirus. The compound is represented by Formula (1) and its pharmaceutically acceptable salt or hydrate. GlobalData’s report on KYORIN gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on KYORIN, was a key innovation area identified from patents. KYORIN's grant share as of May 2024 was 51%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11952387B2) discloses a compound represented by Formula (1) and its various pharmacologically acceptable forms, including salts and hydrates. The compound is characterized by specific structural features outlined in the claims, such as the presence of certain substituents and functional groups. The patent covers a range of compounds falling under Formula (1) as listed in Tables 1 to 11, indicating a broad scope of protection for these antiviral agents.
Moreover, the patent extends to pharmaceutical compositions containing the disclosed compound as an active ingredient, along with a suitable carrier. The compound is identified as an antiviral agent effective against viruses belonging to the Picornaviridae family, including enteroviruses, rhinoviruses, and coxsackieviruses. Additionally, the patent claims methods for treating or preventing viral infections caused by these viruses, as well as exacerbations of asthma or COPD. The methods involve administering the compound or its pharmacologically acceptable forms to individuals in need of such treatment, highlighting the therapeutic potential of the disclosed compound in addressing these medical conditions.
To know more about GlobalData’s detailed insights on KYORIN, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
